These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18822426)

  • 21. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.
    Festen DA; Wevers M; Lindgren AC; Böhm B; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):919-25. PubMed ID: 18031326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden death in Prader-Willi syndrome during growth hormone therapy.
    Sacco M; Di Giorgio G
    Horm Res; 2005; 63(1):29-32. PubMed ID: 15583479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
    Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
    Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal analysis of adolescent growth of foot length and stature of children living in Ogi area of Japan: a 12 years data.
    Liu KM; Shinoda K; Akiyoshi T; Watanabe H
    Z Morphol Anthropol; 1998; 82(1):87-101. PubMed ID: 9850633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of birth size on body composition in early adulthood: the programming factors for growth and metabolism (PROGRAM)-study.
    Leunissen RW; Stijnen T; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):245-51. PubMed ID: 18616715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome.
    Dykens EM; Roof E; Hunt-Hawkins H
    J Child Psychol Psychiatry; 2017 Jan; 58(1):64-74. PubMed ID: 27481444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy.
    Al-Saleh S; Al-Naimi A; Hamilton J; Zweerink A; Iaboni A; Narang I
    J Pediatr; 2013 Feb; 162(2):263-8.e1. PubMed ID: 22947651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin levels in young children with Prader-Willi syndrome.
    Erdie-Lalena CR; Holm VA; Kelly PC; Frayo RS; Cummings DE
    J Pediatr; 2006 Aug; 149(2):199-204. PubMed ID: 16887433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving body composition and physical activity in Prader-Willi Syndrome.
    Eiholzer U; Nordmann Y; l'Allemand D; Schlumpf M; Schmid S; Kromeyer-Hauschild K
    J Pediatr; 2003 Jan; 142(1):73-8. PubMed ID: 12520259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity levels of persons with Prader-Willi syndrome.
    Nardella MT; Sulzbacher SI; Worthington-Roberts BS
    Am J Ment Defic; 1983 Mar; 87(5):498-505. PubMed ID: 6837640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early diagnosis and multidisciplinary care reduce the hospitalization time and duration of tube feeding and prevent early obesity in PWS infants.
    Bacheré N; Diene G; Delagnes V; Molinas C; Moulin P; Tauber M
    Horm Res; 2008; 69(1):45-52. PubMed ID: 18059083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy.
    Eiholzer U; l'Allemand D; van der Sluis I; Steinert H; Gasser T; Ellis K
    Horm Res; 2000; 53(4):200-6. PubMed ID: 11044804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of obesity onset on pendular energy transduction at spontaneous walking speed: Prader-Willi versus nonsyndromal obese individuals.
    Malatesta D; Vismara L; Menegoni F; Grugni G; Capodaglio P
    Obesity (Silver Spring); 2013 Dec; 21(12):E586-91. PubMed ID: 23554340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
    Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
    J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body mass index in children with Prader-Willi Syndrome during human growth hormone therapy: a real world situation.
    Dewan T; Chanoine JP
    J Pediatr; 2009 May; 154(5):777-8; author reply 779. PubMed ID: 19364570
    [No Abstract]   [Full Text] [Related]  

  • 36. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G; Trebar B; Baur F; Schweizer R; Ranke MB
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral and psychiatric disorders in Prader-Willi syndrome: a population study in Japan.
    Hiraiwa R; Maegaki Y; Oka A; Ohno K
    Brain Dev; 2007 Oct; 29(9):535-42. PubMed ID: 17314021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral mucosa in children with Prader-Willi syndrome.
    Olczak-Kowalczyk D; Witt A; Gozdowski D; Ginalska-Malinowska M
    J Oral Pathol Med; 2011 Nov; 40(10):778-84. PubMed ID: 21457346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cephalometric analysis of the Prader-Willi syndrome.
    Schaedel R; Poole AE; Cassidy SB
    Am J Med Genet; 1990 Aug; 36(4):484-7. PubMed ID: 2389807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
    Myers SE; Whitman BY; Carrel AL; Moerchen V; Bekx MT; Allen DB
    Am J Med Genet A; 2007 Mar; 143A(5):443-8. PubMed ID: 17103437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.